Medically reviewed by Renita White, MD Perimenopause is the transition period when the female body starts to shift from ...

Acupuncture may support healthy gut motility9 (i.e., the pace at which food is digested and moves through your body). This, ...

Click here to get the full newsletter in your inbox, including answers to reader questions and a summary of new scientific ...

Veozah is an oral, neurokinin 3 receptor antagonist indicated for the treatment of moderate to severe vasomotor symptoms due to menopause. The labeling for the product now includes a boxed warning ...

Elinzanetant is under development for the treatment of sex hormone-related conditions in women such as vasomotor symptoms of menopause (hot flashes). It is a capsule formulation administered orally.

Low doses of antidepressant medications may help reduce symptoms of menopause, including hot flashes. Though these generally are not as effective as hormone replacement therapy, they are an option for ...

The U.S. Food and Drug Administration (FDA) has issued its most serious warning -- a black-box warning -- for Veozah, a medication used to relieve hot flashes ... of Veozah treatment and follow ...

Veozah is an oral, neurokinin 3 receptor antagonist indicated for the treatment of moderate to severe vasomotor symptoms due to menopause. The labeling for the product now includes a boxed warning ...

We discuss its causes, which antidepressants cause this side effect, and hair loss treatment and prevention techniques. The type of hair loss most commonly caused by antidepressants is called ...

Depression treatments can include psychotherapy ... As with any medication, antidepressants may cause side effects. A person should discuss the benefits and risks with their doctor before taking ...

A warning letter is issued when the US health regulator finds that a manufacturer has significantly violated its regulations. Shares of Indoco Remedies on Tuesday ended 1 per cent up at Rs 344 apiece ...

Nvidia stock may be under pressure in the short-term. It slipped below its short-term moving averages, testing for support levels near the 200-day MA. Cramer cautioned investors predicting a ...